Sunstone
  • Home
  • What We Do
  • Investment Strategy
  • Funds
  • People
  • Portfolio
  • News & Insights
  • Download Area
  • Contact
Select Page

Sunstone announces new investment in neuropsychiatric company Synendos Therapeutics

12/11/2020

Sunstone announces new investment in neuropsychiatric company Synendos Therapeutics Copenhagen, 12 November 2020 – Sunstone Life Science Ventures today announces it has invested in a new portfolio company, Synendos Therapeutics AG (“Synendos”), a biopharmaceutical...

Sunstone portfolio company Galecto in successful IPO on Nasdaq Global Market in the US.

30/10/2020

Sunstone portfolio company Galecto in successful IPO on Nasdaq Global Market in the US. Sunstone today announced its portfolio company Galecto, a clinical stage biotech firm focusing on novel therapeutics for fibrosis and inflammatory-related lung diseases,...

Recent Posts

  • Galecto Announces First Patient Treated in Phase 2a Trial of the Oral LOXL2 Inhibitor GB2064 in Myelofibrosis (the MYLOX-1 Trial)
  • Why would you do a US IPO?
  • Synendos Therapeutics Expands Series A to CHF 24 million with new investment
  • M&A multiples in the US – should you go west?
  • Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy

Recent Comments

    Archives

    • August 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • September 2019
    • July 2019
    • May 2019
    • March 2019
    • February 2019

    Categories

    • Ikke-kategoriseret
    • Insights
    • News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Supported by:

    Member of:

    Cookie Policy
    Privacy Policy
    CSR Policy
    Tax Policy

    Supported by:

    Member of:

    Cookie Policy
    Privacy Policy
    CSR Policy
    Tax Policy

    ESG Disclosures    ·     No consideration of sustainability adverse impacts
    Design TR-Media ApS ©2021

    We use cookies on the website sunstone.eu in order to generate statistics and to maximize user-friendliness and improve functionality. By using our website, you consent to our use of cookies. Click on cookie settings below if you wish to disable cookies. Or you can read more about what cookies are, how we use them and how you disable cookies Here.
    Cookie settingsAccept
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT